Jean-Pierre Sommadossi

Companies

• Atea Pharmaceuticals, Inc.Chief executive officer Oct 29, 2020 to now¹
• Atea Pharmaceuticals, Inc.Chair Oct 29, 2020 to now¹
• Atea Pharmaceuticals, Inc.President Oct 29, 2020 to now¹
• ABG Acquisition Corp. IBoard member Feb 16, 2021 to Mar 3, 2023²
• Kezar Life Sciences, Inc.Board member Jun 20, 2018 to Jun 30, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APAtea Pharmaceuticals, Inc. AVIR6,633,855 shares⁴$28.6M at $4.31Feb 3, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 3, 2026Exercised options 300,000 shares at $1.24 of Atea Pharmaceuticals, Inc.⁴
• Jan 31, 2026Shares withheld for tax 106,093 shares at $4.24 of Atea Pharmaceuticals, Inc.⁴
• Jan 31, 2026Exercised options 272,983 shares of Atea Pharmaceuticals, Inc.⁴
• Jan 31, 2025Shares withheld for tax 88,601 shares at $3.06 of Atea Pharmaceuticals, Inc.⁵
• Jan 31, 2025Granted 99,517 shares of Atea Pharmaceuticals, Inc.⁵
• Jan 31, 2025Exercised options 173,467 shares of Atea Pharmaceuticals, Inc.⁵
• Sep 19, 2024Sold 1,841 shares at $4.00 of Atea Pharmaceuticals, Inc.⁶
• Sep 18, 2024Sold 22,187 shares at $4.03 of Atea Pharmaceuticals, Inc.⁶
• Sep 17, 2024Sold 33,941 shares at $4.05 of Atea Pharmaceuticals, Inc.⁶
• Jun 5, 2024Sold 1,006 shares at $4.00 of Atea Pharmaceuticals, Inc.⁷
• Feb 1, 2024Sold 56,910 shares at $3.85 of Atea Pharmaceuticals, Inc.⁸
• Jan 31, 2024Exercised options 173,467 shares of Atea Pharmaceuticals, Inc.⁸